Literature DB >> 15797190

A new mutation of IGHMBP2 gene in spinal muscular atrophy with respiratory distress type 1.

Nobutada Tachi1, Sin Kikuchi, Naoki Kozuka, Azusa Nogami.   

Abstract

This report presents a new mutation in the first Japanese female infant with spinal muscular atrophy with respiratory distress type 1. She manifested the characteristic clinical features, including early-onset respiratory failure due to diaphragmatic paralysis and severe distal muscle weakness. Muscle biopsy in the femoral muscle indicated massive neurogenic changes. Sural nerve biopsy disclosed a moderate reduction of myelinated fibers, predominantly reduced large fibers. She had a novel homozygous missense mutation 2685 C -->A, leading to a T879K substitution in the immunoglobulin mu-binding protein 2 gene. Both parents were heterozygous for this mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797190     DOI: 10.1016/j.pediatrneurol.2004.11.003

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

Review 1.  Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1.

Authors:  Alberto Giannini; Anna Maria Pinto; Giordano Rossetti; Edi Prandi; Danilo Tiziano; Christina Brahe; Nardo Nardocci
Journal:  Intensive Care Med       Date:  2006-09-09       Impact factor: 17.440

2.  Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy.

Authors:  James R Lupski; Claudia Gonzaga-Jauregui; Yaping Yang; Matthew N Bainbridge; Shalini Jhangiani; Christian J Buhay; Christie L Kovar; Min Wang; Alicia C Hawes; Jeffrey G Reid; Christine Eng; Donna M Muzny; Richard A Gibbs
Journal:  Genome Med       Date:  2013-06-27       Impact factor: 11.117

3.  Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide.

Authors:  Barbara Maino; Maria Teresa Ciotti; Pietro Calissano; Sebastiano Cavallaro
Journal:  Int J Mol Sci       Date:  2014-04-01       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.